Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.54 |
| ▸ | CA6 | P23280 | 4/20 | 0.54 |
| ▸ | CA7 | P43166 | 4/20 | 0.54 |
| ▸ | CA9 | Q16790 | 4/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.54 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 0.54 |
| ▸ | CA2 | P00918 | 3/20 | 0.54 |
| ▸ | CA4 | P22748 | 3/20 | 0.54 |
| ▸ | CA5A | P35218 | 3/20 | 0.54 |
| ▸ | F13A1 | P00488 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.54 |
| ▸ | THPO | P40225 | 2/20 | 0.54 |
| ▸ | CA3 | P07451 | 2/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | MTOR | P42345 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1458553 | 1.00 | CA12 (0.54) | CA12CA6CA7CA9CA14 | |
| SCHEMBL1459595 | 1.00 | CA12 (0.54) | CA12CA6CA7CA9CA14 | |
| SCHEMBL1459418 | 1.00 | CA12 (0.54) | CA12CA6CA7CA9CA14 | |
| SCHEMBL1459208 | 0.96 | CA12 (0.54) | CA12CA6CA7CA9CA14 | |
| SCHEMBL1459205 | 0.96 | CA12 (0.54) | CA12CA6CA7CA9CA14 | |
| SCHEMBL1459567 | 0.91 | CA12 (0.54) | CA12CA6CA7CA9CA14 | |
| SCHEMBL1459341 | 0.91 | CA12 (0.54) | CA12CA6CA7CA9CA14 | |
| SCHEMBL1459219 | 0.91 | CA12 (0.54) | CA12CA6CA7CA9CA14 | |
| SCHEMBL1458574 | 0.91 | CA12 (0.54) | CA12CA6CA7CA9CA14 | |
| SCHEMBL1459214 | 0.91 | CA12 (0.54) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8729204-B2 | Compositions and method for producing poly-aminofunctionalized polymerization initiators and corresponding polymers | BRIDGESTONE CORPORATION (JP) | 2014-05-20 | — | — | US | disclosed |
| EP-2475534-B1 | COMPOSITIONS AND METHODS FOR PRODUCING POLY-AMINOFUNCTIONALIZED POLYMERIZATION INITIATORS AND CORRESPONDING POLYMERS | BRIDGESTONE CORP (JP) | 2013-10-23 | — | — | EP | disclosed |
| US-20120259056-A1 | COMPOSITIONS AND METHOD FOR PRODUCING POLY-AMINOFUNCTIONALIZED POLYMERIZATION INITIATORS AND CORRESPONDING POLYMERS | BRIDGESTONE CORPORATION (JP) | 2012-10-11 | — | — | US | disclosed |
| EP-2475534-A1 | COMPOSITIONS AND METHODS FOR PRODUCING POLY-AMINOFUNCTIONALIZED POLYMERIZATION INITIATORS AND CORRESPONDING POLYMERS | Bridgestone Corporation (JP) | 2012-07-18 | — | — | EP | disclosed |
| WO-2011031943-A1 | COMPOSITIONS AND METHODS FOR PRODUCING POLY-AMINOFUNCTIONALIZED POLYMERIZATION INITIATORS AND CORRESPONDING POLYMERS | BRIDGESTONE CORPORATION (JP) | 2011-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120259056-A1 | COMPOSITIONS AND METHOD FOR PRODUCING POLY-AMINOFUNCTIONALIZED POLYMERIZATION INITIATORS AND CORRESPONDING POLYMERS | PARG, PARN, PAM | CA12 4322/4885CA6 4039/4885CA7 3712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.